167 related articles for article (PubMed ID: 18974231)
61. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
[TBL] [Abstract][Full Text] [Related]
62. Evidence against a role of human airway trypsin-like protease--the human analogue of the growth-promoting rat adrenal secretory protease--in adrenal tumourigenesis.
Hahner S; Fassnacht M; Hammer F; Schammann M; Weismann D; Hansen IA; Allolio B
Eur J Endocrinol; 2005 Jan; 152(1):143-53. PubMed ID: 15762198
[TBL] [Abstract][Full Text] [Related]
63. Elevated aromatase expression correlates with cervical carcinoma progression.
Veerapaneni P; Kirma N; Nair HB; Hammes LS; Hall KL; Tekmal RR
Gynecol Oncol; 2009 Sep; 114(3):496-500. PubMed ID: 19555998
[TBL] [Abstract][Full Text] [Related]
64. Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors.
Gao ZH; Suppola S; Liu J; Heikkilä P; Jänne J; Voutilainen R
J Clin Endocrinol Metab; 2002 Mar; 87(3):1170-6. PubMed ID: 11889182
[TBL] [Abstract][Full Text] [Related]
65. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
Almeida MQ; Soares IC; Ribeiro TC; Fragoso MC; Marins LV; Wakamatsu A; Ressio RA; Nishi MY; Jorge AA; Lerario AM; Alves VA; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1458-62. PubMed ID: 20080844
[TBL] [Abstract][Full Text] [Related]
66. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.
Ye P; Mariniello B; Mantero F; Shibata H; Rainey WE
J Endocrinol; 2007 Oct; 195(1):39-48. PubMed ID: 17911395
[TBL] [Abstract][Full Text] [Related]
67. Expression profiles of the glucose-dependent insulinotropic peptide receptor and LHCGR in sporadic adrenocortical tumors.
Costa MH; Latronico AC; Martin RM; Barbosa AS; Almeida MQ; Lotfi CF; Valassi HP; Nishi MY; Lucon AM; Siqueira SA; Zerbini MC; Carvalho LR; Mendonca BB; Fragoso MC
J Endocrinol; 2009 Feb; 200(2):167-75. PubMed ID: 18971217
[TBL] [Abstract][Full Text] [Related]
68. Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes.
Kitamura Y; Sasamura H; Maruyama T; Nakaya H; Amemiya T; Hayashi M; Saruta T
Mol Cell Endocrinol; 1998 Sep; 144(1-2):37-45. PubMed ID: 9863625
[TBL] [Abstract][Full Text] [Related]
69. Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
Watanabe M; Noda M; Nakajin S
J Endocrinol; 2006 Jan; 188(1):59-68. PubMed ID: 16394175
[TBL] [Abstract][Full Text] [Related]
70. Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?
Joubert M; Louiset E; Rego JL; Contesse V; Kong LC; Benhaim A; Mittre H; Lefebvre H; Reznik Y;
Clin Endocrinol (Oxf); 2008 May; 68(5):692-9. PubMed ID: 17980016
[TBL] [Abstract][Full Text] [Related]
71. Expression of steroidogenic factor 1 in canine cortisol-secreting adrenocortical tumors and normal adrenals.
Galac S; Kool MM; van den Berg MF; Mol JA; Kooistra HS
Domest Anim Endocrinol; 2014 Oct; 49():1-5. PubMed ID: 25010021
[TBL] [Abstract][Full Text] [Related]
72. Activating transcription factor 3 (ATF3) in the human adrenal cortex: its possible involvement in aldosterone biosynthesis.
Felizola SJ; Nakamura Y; Ozawa Y; Ono Y; Morimoto R; Midorikawa S; Suzuki S; Satoh F; Sasano H
Tohoku J Exp Med; 2014 Dec; 234(4):249-54. PubMed ID: 25400120
[TBL] [Abstract][Full Text] [Related]
73. ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas.
Arnaldi G; Mancini V; Costantini C; Giovagnetti M; Petrelli M; Masini A; Bertagna X; Mantero F
Endocr Res; 1998; 24(3-4):845-9. PubMed ID: 9888585
[TBL] [Abstract][Full Text] [Related]
74. Purkinje Cell Protein 4 Expression Is Associated With DNA Methylation Status in Aldosterone-Producing Adenoma.
Kobuke K; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Yoshii Y; Yoneda M; Hattori N
J Clin Endocrinol Metab; 2018 Mar; 103(3):965-971. PubMed ID: 29294065
[TBL] [Abstract][Full Text] [Related]
75. Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors.
Szabó PM; Wiener Z; Tömböl Z; Kovács A; Pócza P; Horányi J; Kulka J; Riesz P; Tóth M; Patócs A; Gaillard RC; Falus A; Rácz K; Igaz P
Virchows Arch; 2009 Aug; 455(2):133-42. PubMed ID: 19568768
[TBL] [Abstract][Full Text] [Related]
76. p53 protein and its messenger ribonucleic acid in human adrenal tumors.
Adleff V; Rácz K; Tóth M; Varga I; Bezzegh A; Gláz E
J Endocrinol Invest; 1998 Dec; 21(11):753-7. PubMed ID: 9972675
[TBL] [Abstract][Full Text] [Related]
77. Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma.
Advani A; Johnson SJ; Nicol MR; Papacleovoulou G; Evans DB; Vaikkakara S; Mason JI; Quinton R
Endocr J; 2010; 57(7):651-6. PubMed ID: 20467160
[TBL] [Abstract][Full Text] [Related]
78. Genetic Causes of Functional Adrenocortical Adenomas.
Zennaro MC; Boulkroun S; Fernandes-Rosa F
Endocr Rev; 2017 Dec; 38(6):516-537. PubMed ID: 28973103
[TBL] [Abstract][Full Text] [Related]
79. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?
Sanderson JT; Seinen W; Giesy JP; van den Berg M
Toxicol Sci; 2000 Mar; 54(1):121-7. PubMed ID: 10746939
[TBL] [Abstract][Full Text] [Related]
80. Steroid contents and cortical steroidogenic enzymes in non-hyperfunctioning adrenal adenoma.
Suzuki H; Shibata H; Takita T; Wakino S; Ogishima T; Ishimura Y; Saruta T
Endocr J; 1994 Jun; 41(3):267-74. PubMed ID: 7951578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
